Ivan Cheung
Vermogen: 200 952 $ op 31-08-2026
Vermogen: 200 952 $ op 31-08-2026
Ivan H.
Cheung is Chief Executive Officer & Director at Nextpoint Therapeutics, Inc. since 2024.
Ivan is also Director at Pharmaceutical Research & Manufacturers of America and Japanese Chamber of Commerce & Industry of New York, Inc. Ivan serves as Independent Director at Lexicon Pharmaceuticals, Inc. starting in 2024.
Formerly, Ivan was Chairman & Chief Executive Officer at Eisai, Inc. from 2016 to 2023.
Ivan was Executive Officer at Eisai Co., Ltd. from 2011 to 2016.
Ivan completed undergraduate studies at Duke University and earned an MBA from Harvard Business School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-06-2026 | 89.312 ( 0,02% ) | 200 952 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 02-12-2024 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Bestuurslid | - |
Japanese Chamber of Commerce & Industry of New York, Inc.
Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Hosts panel discussions, lectures, seminars and training programs | Directeur/Bestuurslid | - |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Algemeen Directeur | 01-02-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Algemeen Directeur | 31-07-2023 |
| EISAI CO., LTD. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Eisai Co., Ltd.
Eisai Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacturing and sales of prescription and over-the-counter drugs | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Japanese Chamber of Commerce & Industry of New York, Inc.
Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Hosts panel discussions, lectures, seminars and training programs | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau